What are the magnetic resonance imaging characteristics of primary bone lymphoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MRI Characteristics of Primary Bone Lymphoma

Primary bone lymphoma on MRI characteristically shows diffuse and homogeneous bone marrow infiltration on T1-weighted images, with an "infarct-like" enhancement pattern being highly suggestive, particularly when lesions involve the epiphysis around the knee with sharp T1 margins and surrounding soft tissue edema. 1

Key MRI Features

Signal Characteristics

  • T1-weighted images: Homogeneous low to isointense signal with sharp, well-defined margins (present in 60% of cases) 1
  • T2-weighted images: Mixed signals - can appear isointense, hyperintense, or show an "infarct-like" appearance (70% of cases) 12
  • The infarct-like pattern is particularly characteristic and should raise strong suspicion for lymphoma

Enhancement Pattern

Infarct-like enhancement is the most distinctive feature, occurring in 88% of cases with post-contrast imaging 1. This pattern shows:

  • Geographic areas of enhancement
  • Central non-enhancing regions mimicking bone infarction
  • Marked but inhomogeneous enhancement overall 32

Anatomic Distribution

  • Epiphyseal involvement is highly characteristic: 80% of patients have at least one epiphyseal lesion, with 50% having lesions confined entirely to the epiphysis 1
  • Predilection for the knee region: 80% of patients have lesions around the knee 1
  • Femur is the most commonly affected bone (70% of cases) 1
  • Multifocal disease occurs in 40% of cases 1

Associated Findings

  • Soft tissue edema: Present in 80% of cases, often disproportionate to the degree of cortical destruction 14
  • Soft tissue mass: Relatively uncommon (only 10% of cases), which helps distinguish lymphoma from other aggressive bone tumors 1
  • Cortical disruption: Minimal, present in only 30% of cases despite aggressive appearance 14
  • Regional lymphadenopathy: PET-positive lymph nodes in 30% of cases 1

Diagnostic Pitfalls

Critical Caveats

STIR sequences can be misleading - bone marrow may appear normal on short-τ inversion recovery images, potentially causing misdiagnosis. Dixon fat-only sequences are superior for detecting bone marrow infiltration with greater conspicuity 55.

Extensive necrosis can mimic osteomyelitis on both MRI and FDG-PET/CT, obscuring viable tumor and leading to diagnostic delay. This requires targeted repeat biopsy if initial sampling is non-diagnostic 6.

Distinguishing Features from Other Bone Tumors

Unlike osteosarcoma:

  • Less cortical destruction relative to marrow involvement
  • Minimal periosteal reaction (when present, may be laminar rather than aggressive) 3
  • Epiphyseal involvement is common in lymphoma but rare in osteosarcoma

Unlike osteomyelitis:

  • Sharp T1 margins rather than ill-defined
  • Infarct-like enhancement pattern
  • Less surrounding soft tissue inflammation relative to bone involvement

Advanced Imaging Considerations

Diffusion-weighted imaging (DWI) is valuable due to the high cellularity of lymphoma:

  • Shows restricted diffusion
  • Helpful for identifying sites of involvement 55
  • Demonstrates significant ADC value differences between responders and non-responders post-treatment 55

Whole-body MRI should be considered for:

  • Detecting multifocal disease (present in 40% of cases)
  • Staging without radiation exposure
  • Surveillance in young patients 55

Post-Treatment Imaging

Residual osseous abnormality on MRI is expected at follow-up in 100% of cases, with 60% maintaining an infarct-like or combination appearance. This should not be mistaken for treatment failure 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.